Stabilization of homocysteine in unseparated blood over several days: a solution for epidemiological studies.

of pyridoxal 5 -phosphate. Biochim Biophys Acta 1973;304:765–73. 13. Dalton K, Dalton MT. Characteristics of pyridoxine overdose neuropathy syndromes. Acta Neurol Scand 1987;76:8–11. 14. Ubbink JB, Serfontein WJ, De Villiers LS. Stability of pyridoxal 5 -phosphate semicarbazone: applications in plasma vitamin B6 analysis and population surveys of vitamin B6 nutritional status. J Chromatogr B Biomed Sci Appl 1985;342:277–84. 15. Millart H, Lamiable D. Determination of pyridoxal 5 -phosphate in human serum by reversed phase high performance liquid chromatography combined with spectrofluorometric detection of 4-pyridoxic acid 5 -phosphate as a derivative. Analyst 1989;114:1225–8. 16. Bates CJ, Pentieva KD, Mathews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5 -phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999;280:101–11. 17. Bailey AL, Wright AJ, Southon S. High performance liquid chromatography method for the determination of pyridoxal 5 -phosphate in human plasma: how appropriate are cut-off values for vitamin B6 deficiency? Eur J Clin Nutr 1999;53:448–55. 18. Edwards P, Liu P, Alan Rose G. A simple chromatographic method for measuring vitamin B6 compounds in plasma. Clin Chem 1989;35:241–5. 19. Kimura M, Kanehira K, Yokoi K. Highly sensitive and simple liquid chromatographic determination in plasma of B6 vitamers, especially pyridoxal 5 phosphate. J Chromatogr A 1996;722:295–301. 20. Deitrick CL, Katholi RE, Huddleston DJ, Hardiek K, Burrus L. Clinical adaptation of a high performance liquid chromatographic method for the assay of pyridoxal 5 -phosphate in human plasma. J Chromatogr B Biomed Sci Appl 2001;751:383–7. 21. Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D. Blood vitamin concentrations during the acute phase response. Crit Care Med 1992;20:934–41.